• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与帕金森病大脑分子变化及临床结局相关的血液转录组学特征。

Blood transcriptomic signatures associated with molecular changes in the brain and clinical outcomes in Parkinson's disease.

机构信息

Laboratory of Molecular Neuro-oncology, The Rockefeller University, 1230 York Avenue, New York, NY, 10065, USA.

Bioinformatics Resource Center, The Rockefeller University, 1230 York Avenue, New York, NY, 10065, USA.

出版信息

Nat Commun. 2023 Jul 5;14(1):3956. doi: 10.1038/s41467-023-39652-6.

DOI:10.1038/s41467-023-39652-6
PMID:37407548
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10322907/
Abstract

The ability to use blood to predict the outcomes of Parkinson's disease, including disease progression and cognitive and motor complications, would be of significant clinical value. We undertook bulk RNA sequencing from the caudate and putamen of postmortem Parkinson's disease (n = 35) and control (n = 40) striatum, and compared molecular profiles with clinical features and bulk RNA sequencing data obtained from antemortem peripheral blood. Cognitive and motor complications of Parkinson's disease were associated with molecular changes in the caudate (stress response) and putamen (endothelial pathways) respectively. Later and earlier-onset Parkinson's disease were molecularly distinct, and disease duration was associated with changes in caudate (oligodendrocyte development) and putamen (cellular senescence), respectively. Transcriptome patterns in the postmortem Parkinson's disease brain were also evident in antemortem peripheral blood, and correlated with clinical features of the disease. Together, these findings identify molecular signatures in Parkinson's disease patients' brain and blood of potential pathophysiologic and prognostic importance.

摘要

利用血液预测帕金森病的结果(包括疾病进展和认知及运动并发症)将具有重要的临床价值。我们对帕金森病(n=35)和对照组(n=40)死后纹状体的尾状核和壳核进行了 bulk RNA 测序,并将分子谱与临床特征以及从生前外周血获得的 bulk RNA 测序数据进行了比较。帕金森病的认知和运动并发症分别与尾状核(应激反应)和壳核(血管内皮途径)的分子变化相关。晚发性和早发性帕金森病在分子上是不同的,疾病持续时间分别与尾状核(少突胶质细胞发育)和壳核(细胞衰老)的变化相关。帕金森病患者死后大脑中的转录组模式也存在于生前外周血中,并与疾病的临床特征相关。总之,这些发现确定了帕金森病患者大脑和血液中具有潜在病理生理和预后重要性的分子特征。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c43/10322907/fad9fa291cd0/41467_2023_39652_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c43/10322907/c4b236f70d0b/41467_2023_39652_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c43/10322907/7b3a1371ac23/41467_2023_39652_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c43/10322907/0a2faf5c85bf/41467_2023_39652_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c43/10322907/683278f098ba/41467_2023_39652_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c43/10322907/fad9fa291cd0/41467_2023_39652_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c43/10322907/c4b236f70d0b/41467_2023_39652_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c43/10322907/7b3a1371ac23/41467_2023_39652_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c43/10322907/0a2faf5c85bf/41467_2023_39652_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c43/10322907/683278f098ba/41467_2023_39652_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c43/10322907/fad9fa291cd0/41467_2023_39652_Fig5_HTML.jpg

相似文献

1
Blood transcriptomic signatures associated with molecular changes in the brain and clinical outcomes in Parkinson's disease.与帕金森病大脑分子变化及临床结局相关的血液转录组学特征。
Nat Commun. 2023 Jul 5;14(1):3956. doi: 10.1038/s41467-023-39652-6.
2
Regional striatal DOPA transport and decarboxylase activity in Parkinson's disease.帕金森病中纹状体区域的多巴转运及脱羧酶活性
J Nucl Med. 1995 Jul;36(7):1226-31.
3
Usefulness of a dopamine transporter PET ligand [(18)F]beta-CFT in assessing disability in Parkinson's disease.多巴胺转运体PET配体[(18)F]β-CFT在评估帕金森病残疾程度中的应用价值。
J Neurol Neurosurg Psychiatry. 1999 Dec;67(6):737-41. doi: 10.1136/jnnp.67.6.737.
4
Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications.特发性帕金森病患者纹状体中多巴胺丧失的不均匀模式。病理生理学及临床意义。
N Engl J Med. 1988 Apr 7;318(14):876-80. doi: 10.1056/NEJM198804073181402.
5
Separating Parkinson's disease from normality. Discriminant function analysis of fluorodopa F 18 positron emission tomography data.区分帕金森病与正常状态。氟多巴F 18正电子发射断层扫描数据的判别函数分析。
Arch Neurol. 1994 Mar;51(3):237-43. doi: 10.1001/archneur.1994.00540150027011.
6
Striatal opioid receptor binding in Parkinson's disease, striatonigral degeneration and Steele-Richardson-Olszewski syndrome, A [11C]diprenorphine PET study.帕金森病、纹状体黑质变性和斯蒂尔-理查森-奥尔谢夫斯基综合征中纹状体阿片受体结合情况:一项[11C]二丙诺啡正电子发射断层扫描研究
Brain. 1995 Aug;118 ( Pt 4):951-8. doi: 10.1093/brain/118.4.951.
7
Severe depletion of cocaine recognition sites associated with the dopamine transporter in Parkinson's-diseased striatum.帕金森病纹状体中与多巴胺转运体相关的可卡因识别位点严重耗竭。
Synapse. 1991 Sep;9(1):43-9. doi: 10.1002/syn.890090107.
8
Test/retest reproducibility of iodine-123-betaCIT SPECT brain measurement of dopamine transporters in Parkinson's patients.帕金森病患者中碘-123-β-CIT单光子发射计算机断层扫描脑多巴胺转运体测量的重测信度
J Nucl Med. 1997 Sep;38(9):1453-9.
9
Distinct dopaminergic abnormalities in traumatic brain injury and Parkinson's disease.创伤性脑损伤和帕金森病中多巴胺能异常的特征。
J Neurol Neurosurg Psychiatry. 2020 Jun;91(6):631-637. doi: 10.1136/jnnp-2019-321759. Epub 2020 May 7.
10
Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution.路易体痴呆、阿尔茨海默病和帕金森病中的纹状体多巴胺能标记物:前后分布
Brain. 1999 Aug;122 ( Pt 8):1449-68. doi: 10.1093/brain/122.8.1449.

引用本文的文献

1
A blood-based DNA damage signature in patients with Parkinson's disease is associated with disease progression.帕金森病患者基于血液的DNA损伤特征与疾病进展相关。
Nat Aging. 2025 Sep 5. doi: 10.1038/s43587-025-00926-x.
2
Parkinson's Disease: Bridging Gaps, Building Biomarkers, and Reimagining Clinical Translation.帕金森病:弥合差距、构建生物标志物及重塑临床转化
Cells. 2025 Jul 28;14(15):1161. doi: 10.3390/cells14151161.
3
DualGCN-GE: integration of spatiotemporal representations from whole-blood expression data with dual-view graph convolution network to identify Parkinson's disease subtypes.

本文引用的文献

1
RNA sequencing of whole blood reveals early alterations in immune cells and gene expression in Parkinson's disease.全血 RNA 测序揭示帕金森病中免疫细胞和基因表达的早期改变。
Nat Aging. 2021 Aug;1(8):734-747. doi: 10.1038/s43587-021-00088-6. Epub 2021 Aug 5.
2
A Machine Learning Approach to Parkinson's Disease Blood Transcriptomics.基于机器学习的帕金森病血液转录组学研究方法。
Genes (Basel). 2022 Apr 21;13(5):727. doi: 10.3390/genes13050727.
3
Striatal synaptic adaptations in Parkinson's disease.帕金森病患者纹状体突触适应性变化。
DualGCN-GE:将全血表达数据的时空表征与双视图图卷积网络相结合以识别帕金森病亚型
BMC Bioinformatics. 2025 Aug 12;26(1):208. doi: 10.1186/s12859-025-06181-6.
4
Large-scale plasma proteomics uncovers preclinical molecular signatures of Parkinson's disease and overlap with other neurodegenerative disorders.大规模血浆蛋白质组学揭示帕金森病的临床前分子特征及其与其他神经退行性疾病的重叠情况。
medRxiv. 2025 Jul 30:2025.07.30.25332433. doi: 10.1101/2025.07.30.25332433.
5
Mitochondrial dysfunction-mediated metabolic remodeling of TCA cycle promotes Parkinson's disease through inhibition of H3K4me3 demethylation.线粒体功能障碍介导的三羧酸循环代谢重塑通过抑制H3K4me3去甲基化促进帕金森病。
Cell Death Discov. 2025 Jul 29;11(1):351. doi: 10.1038/s41420-025-02651-1.
6
A Comprehensive Study of Circulating Blood Linear RNA nominates and as novel causal genes and early-stage biomarkers for Parkinson's Disease.一项关于循环血液线性RNA的综合研究将[具体基因1]和[具体基因2]确定为帕金森病的新型致病基因和早期生物标志物。
medRxiv. 2025 Jun 20:2025.06.20.25329948. doi: 10.1101/2025.06.20.25329948.
7
Whole-blood transcriptomic analysis reveals preoperative complement inhibitor deficiencies linked to postoperative delirium.全血转录组分析揭示术前补体抑制剂缺乏与术后谵妄有关。
Mol Psychiatry. 2025 May 27. doi: 10.1038/s41380-025-03063-4.
8
Synphilin-1 regulates mechanotransduction in rigidity sensing through interaction with zyxin.α-突触核蛋白-1通过与桩蛋白相互作用调节硬度感知中的机械转导。
J Nanobiotechnology. 2025 May 14;23(1):345. doi: 10.1186/s12951-025-03429-4.
9
Tet2 loss and enhanced ciliogenesis suppress α-synuclein pathology.Tet2缺失和纤毛生成增强可抑制α-突触核蛋白病变。
Acta Neuropathol Commun. 2025 Apr 7;13(1):71. doi: 10.1186/s40478-025-01988-z.
10
Identification of critical genes and drug repurposing targets in entorhinal cortex of Alzheimer's disease.阿尔茨海默病内嗅皮层关键基因的鉴定及药物再利用靶点
Neurogenetics. 2025 Feb 10;26(1):27. doi: 10.1007/s10048-025-00806-x.
Neurobiol Dis. 2022 Jun 1;167:105686. doi: 10.1016/j.nbd.2022.105686. Epub 2022 Mar 8.
4
Cell types of origin of the cell-free transcriptome.无细胞转录组的细胞起源类型。
Nat Biotechnol. 2022 Jun;40(6):855-861. doi: 10.1038/s41587-021-01188-9. Epub 2022 Feb 7.
5
The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences.PRIDE 数据库资源在 2022 年:一个基于质谱的蛋白质组学证据的中心。
Nucleic Acids Res. 2022 Jan 7;50(D1):D543-D552. doi: 10.1093/nar/gkab1038.
6
A geroscience motivated approach to treat Alzheimer's disease: Senolytics move to clinical trials.衰老生物学驱动的阿尔茨海默病治疗方法:衰老细胞清除剂进入临床试验。
Mech Ageing Dev. 2021 Dec;200:111589. doi: 10.1016/j.mad.2021.111589. Epub 2021 Oct 21.
7
The cryptic gonadotropin-releasing hormone neuronal system of human basal ganglia.人类基底神经节中神秘的促性腺激素释放激素神经元系统。
Elife. 2021 Jun 15;10:e67714. doi: 10.7554/eLife.67714.
8
The Rac-GEF Tiam1 Promotes Dendrite and Synapse Stabilization of Dentate Granule Cells and Restricts Hippocampal-Dependent Memory Functions.Rac-GEF Tiam1 促进齿状回颗粒细胞的树突和突触稳定,并限制海马依赖性记忆功能。
J Neurosci. 2021 Feb 10;41(6):1191-1206. doi: 10.1523/JNEUROSCI.3271-17.2020. Epub 2020 Dec 16.
9
Noninvasive characterization of Alzheimer's disease by circulating, cell-free messenger RNA next-generation sequencing.通过循环、无细胞信使 RNA 下一代测序对阿尔茨海默病进行无创特征分析。
Sci Adv. 2020 Dec 9;6(50). doi: 10.1126/sciadv.abb1654. Print 2020 Dec.
10
Elevated caudate connectivity in cognitively normal Parkinson's disease patients.认知正常的帕金森病患者尾状核连接增高。
Sci Rep. 2020 Oct 21;10(1):17978. doi: 10.1038/s41598-020-75008-6.